Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Journal CME

Journal CME 36.05: A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease

Length:60 MinutesCME Credits:1Release Date:Jun 25, 2021

Experienced / IntermediateJournal CME

Program Description

The Journal CME36.05 article provided a brief evaluation of whether Lovastatin has the potential to slow motor symptom progression in patients with early- stage Parkinson's disease.

Topics

  • Parkinson Disease/Hypokinetic Movement Disorders
  • Therapies-Pharmacological

Faculty

Chin-Hsien Lin, MD, PhD

Course Purpose

Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.

Learning Objectives

Upon completion of this activity learners will be able to:
1. Understand the improved benefit lovastatin may have over other statins for the treatment of neurodegenerative diseases
2. Evaluate how lovastatin may have a symptomatic effect in motor symptom progression rather than neuroprotective effect in PD
3. Consider the limitations of the study and how they might affect the outcome

Intended Audience

This activity is intended for physicians, fellows or other practitioners in the field of Movement Disorders with an emphasis on current practice trends.

Accreditation Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

 

Credit Designation Statement

The International Parkinson and Movement Disorder Society designates this education activity for a maximum 1.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Method of Participation

This activity will take approximately 1 hour to complete. To receive credit, participants are required to complete the view the online activity and complete the post-test and evaluation. To receive credit, 75% must be achieved on the post test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact education@movementdisorders.org.

Faculty Disclosure

JOURNALCME36-05-Discl

Staff Disclosure

MDS staff members involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Hardware and Software Requirements

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher).
5. Adobe Reader to print certificate.

Contact Us

MDS Education

MDS Secretariat Liaison

Ericka Blackford

Disclaimer

All individuals in control of content for this course are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME.

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice